Clinical Trial Update: Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravitreal triamcinolone for diffuse diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Macular Edema

Drugs mentioned

• Triamcinolone (triamcinolone)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Diabetes Mellitus, Macular Edema | Phase 3 | Status: COMPLETED